1. Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: Results of a Randomized Phase 3 Placebo-Controlled Study (Study 301). (April 2023) Authors: Sachs, Gary S.; Yeung, Paul P.; Rekeda, Ludmyla; Khan, Arifulla; Adams, Julie L.; Fava, Maurizio Journal: CNS spectrums Issue: Volume 28:Number 2(2023) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study. (6th November 2019) Authors: Earley, Willie R.; Burgess, Maria V.; Khan, Barbara; Rekeda, Ludmyla; Suppes, Trisha; Tohen, Mauricio; Calabrese, Joseph R. Journal: Bipolar disorders Issue: Volume 22:Number 4(2020) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase 3, Randomized, Double-blind Noninferiority (NI) Study of Ceftazidime–Avibactam (CAZ-AVI) vs. Meropenem (MER) in the Treatment of Patients with Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia (HABP/VABP): Analyses of the REPROVE Study per US FDA Endpoints. (4th October 2017) Authors: Torres, Antoni; Rank, Doug; Rekeda, Ludmyla; Chen, Xiang; Riccobene, Todd; Critchley, Ian; Lakkis, Hassan; Melnick, David; Chow, Joseph W; Taylor, Dianna; Laud, Peter J; Talley, Angela K Journal: Open forum infectious diseases Issue: Volume 4(2017)Supplement 1 Page Start: S535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD. (August 2013) Authors: van der Palen, Job; Ginko, Thomas; Kroker, Axel; van der Valk, Paul; Goosens, Martijn; Padullés, Laura; Seoane, Beatriz; Rekeda, Ludmyla; Garcia Gil, Esther Journal: Expert opinion on drug delivery Issue: Volume 10:Number 8(2013:Aug.) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA–Specified End Points. (25th April 2019) Authors: Torres, Antoni; Rank, Doug; Melnick, David; Rekeda, Ludmyla; Chen, Xiang; Riccobene, Todd; Critchley, Ian A; Lakkis, Hassan D; Taylor, Dianna; Talley, Angela K Journal: Open forum infectious diseases Issue: Volume 6:Number 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety and Tolerability of Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: A Pooled Analysis of Phase 2B and 3 Clinical Trials. (April 2023) Authors: Thase, Michael E.; Yeung, Paul P.; Hankinson, Arlene; Liu, Meng; Rekeda, Ludmyla; Earley, Willie R. Journal: CNS spectrums Issue: Volume 28:Number 2(2023) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗